We present a Peruvian human immunodeficiency virus (HIV)-positive patient receiving first-line therapy for tuberculosis who presents with neurological complications to highlight some of the major issues in the diagnosis and management of human immunodeficiency virus—related central nervous system complications in resource-poor settings. These include limited options for diagnosing extrapulmonary and drug-resistant tuberculosis; the importance of central nervous system . imaging; and the management conundrum when faced with a broad differential diagnosis. This patient waswith drug-resistant tuberculosis of the brain, unmasked by immunologic recovery in the setting of recent initiation of antiretroviral treatment. We argue that aggressive and timely empiric multidrug-resistant tuberculosis treatment is important in cases where drug-resistant tuberculosis is suspected. Knowledge gaps include a limited understanding of immune reconstitution and the optimal timing of antiretroviral treatment in the setting of drug-resistant tuberculosis.
Wells KB, Stewart A., Hays RD, et al. The functioning and well-being of depressed patients. Results from the Medical Outcomes Study. JAMA. 1989 ;262:914-919.
2.
Padayatchi N. , Bamber S., Dawood H., Bobat R.Multidrug-resistant tuberculous meningitis in children in Durban, South Africa. Pediatr Infect Dis J . 2006;25: 147-150.
3.
Meybeck A., Calbet J., Ruimy R., Mashri K., Jachym M., Joly V., Yeni P.Multidrug-resistant tuberculous meningitis in an HIV-positive patient: a challenging disease. AIDS Patient Care STDS. 2007;21:149-153.
Cecchini D., Ambrosioni J., Brezzo C., et al. Tuberculous meningitis in HIV-infected patients: drug susceptibility and clinical outcome. AIDS. 2007;21:373-374.
6.
Kwara A., Roahen-Harrison S., Prystowsky E., et al. Manifestations and outcome of extra-pulmonary tuberculosis: impact of human immunodeficiency virus coinfection. Int J Tuberc Lung Dis. 2005;9:485-493.
7.
Rock RB, Olin M., Baker CA, Molitor TW, Peterson PKCentral nervous system tuberculosis: pathogenesis and clinical aspects . Clin Microbiol Rev. 2008;21:243-261, table of contents.
8.
Daley P., Thomas S., Pai M.Nucleic acid amplification tests for the diagnosis of tuberculous lymphadenitis: a systematic review. Int J Tuberc Lung Dis . 2007;11: 1166-1176.
9.
Dinnes J., Deeks J., Kunst H., et al. A systematic review of rapid diagnostic tests for the detection of tuberculosis infection. Health Technol Assess. 2007;11:1-196.
10.
Martin A., Panaiotov S., Portaels F., Hoffner S., Palomino JC, Angeby K.The nitrate reductase assay for the rapid detection of isoniazid and rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis . J Antimicrob Chemother. 2008 ;62:56-64.
11.
Storla DG, Yimer S., Bjune GAA systematic review of delay in the diagnosis and treatment of tuberculosis . BMC Public Health. 2008;8:15.
12.
Moore DA, Evans CA, Gilman RH, et al. Microscopic-observation drug-susceptibility assay for the diagnosis of TB. N Engl J Med. 2006;355:1539-1550.
13.
Acquired rifamycin resistance in persons with advanced HIV disease being treated for active tuberculosis with intermittent rifamycin-based regimens. MMWR Morb Mortal Wkly Rep. 2002;51:214-215.
14.
Burman W., Benator D., Vernon A., et al. Acquired rifamycin resistance with twice-weekly treatment of HIVrelated tuberculosis. Am J Respir Crit Care Med. 2006;173:350-356.
15.
Li J., Munsiff SS, Driver CR, Sackoff J.Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutinbased regimens in New York City, 1997-2000 . Clin Infect Dis. 2005 ;41:83-91.
16.
Eza D., Cerrillo G., Moore DA, Castro C., Ticona E., Morales D., et al. Postmortem findings and opportunistic infections in HIV-positive patients from a public hospital in Peru. Pathol Res Pract . 2006;202:767-775.
17.
Arias M., Mello FC, Pavon A., et al. Clinical evaluation of the microscopic-observation drug-susceptibility assay for detection of tuberculosis. Clin Infect Dis. 2007;44: 674-680.
18.
Caws M., Dang TM, Torok E., Campbell J., Do DA, Tran TH, et al. Evaluation of the MODS culture technique for the diagnosis of tuberculous meningitis. PLoS ONE. 2007;2:e1173.
19.
Lama JR, Sanchez J., Suarez L., et al. Linking HIV and antiretroviral drug resistance surveillance in Peru: a model for a third-generation HIV sentinel surveillance. J Acquir Immune Defic Syndr. 2006;42:501-505.
20.
Nic Fhogartaigh CJ, Vargas-Prada S., Huancare V., Lopez S., Rodriguez J., Moore DAPhysician-initiated courtesy MODS testing for TB and MDR-TB diagnosis and patient management. Int J Tuberc Lung Dis. 2008;12:555-560.
21.
Yagui M., Perales MT, Asencios L., et al. Timely diagnosis of MDR-TB under program conditions: is rapid drug susceptibility testing sufficient? Int J Tuberc Lung Dis. 2006;10:838-843.
22.
Migliori GB , Espinal M., Danilova ID, Punga VV, Grzemska M., Raviglione MCFrequency of recurrence among MDR-tB cases `successfully' treated with standardised short-course chemotherapy. Int J Tuberc Lung Dis. 2002;6:858-864.
23.
Bekker LG, Myer L., Orrell C., Lawn S., Wood R.Rapid scale-up of a community-based HIV treatment service: programme performance over 3 consecutive years in Guguletu, South Africa. S Afr Med J. 2006;96:315-320.
24.
McIlleron H. , Meintjes G., Burman WJ, Maartens G.Complications of antiretroviral therapy in patients with tuberculosis: drug interactions, toxicity, and immune reconstitution inflammatory syndrome. J Infect Dis. 2007 ;196(suppl 1):S63-S75.
25.
Cheng VC, Yam WC, Woo PC, et al. Risk factors for development of paradoxical response during antituberculosis therapy in HIV-negative patients. Eur J Clin Microbiol Infect Dis. 2003;22:597-602.
26.
Hejazi N., Hassler W.Multiple intracranial tuberculomas with atypical response to tuberculostatic chemotherapy: literature review and a case report. Infection . 1997;25: 233-239.
27.
Breen RA, Smith CJ, Cropley I., Johnson MA, Lipman MCDoes immune reconstitution syndrome promote active tuberculosis in patients receiving highly active antiretroviral therapy? AIDS. 2005;19:1201-1206.
28.
Lawn SD, Bekker LG, Miller RFImmune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals. Lancet Infect Dis. 2005;5:361-73.
29.
Ansari NA, Kombe AH, Kenyon TA, et al. Pathology and causes of death in a group of 128 predominantly HIV-positive patients in Botswana, 1997-1998. Int J Tuberc Lung Dis. 2002;6:55-63.
30.
Flora GS, Modilevsky T., Antoniskis D., Barnes PFUndiagnosed tuberculosis in patients with human immunodeficiency virus infection . Chest. 1990;98:1056-1059.
31.
Martinson NA , Karstaedt A., Venter WD, et al. Causes of death in hospitalized adults with a premortem diagnosis of tuberculosis: an autopsy study. AIDS. 2007;21: 2043-2050.
32.
Rana FS, Hawken MP, Mwachari C., et al. Autopsy study of HIV-1-positive and HIV-1-negative adult medical patients in Nairobi, Kenya. J Acquir Immune Defic Syndr. 2000;24:23-29.
33.
Satyanarayana S., Kalghatgi AT, Malaviya AK, et al. Needle necropsy in AIDS. Indian J Pathol Microbiol. 2003;46:416-419.
34.
Kaufer DI, Cummings JL, Ketchel P., et al. Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci. 2000;12: 233-239.
35.
Nogueira Campos L., De Fatima Bonolo P , Crosland Guimaraes MDAnxiety and depression assessment prior to initiating antiretroviral treatment in Brazil. AIDS Care. 2006;18:529-536.
36.
Schiffer JT , Sterling TRTiming of antiretroviral therapy initiation in tuberculosis patients with AIDS: a decision analysis. J Acquir Immune Defic Syndr. 2007;44: 229-234.
37.
Kawai V., Soto G., Gilman RH, et al. Tuberculosis mortality, drug resistance, and infectiousness in patients with and without HIV infection in Peru. Am J Trop Med Hyg. 2006;75:1027-1033.
38.
Saravia JC, Appleton SC, Rich ML, Sarria M., Bayona J., Becerra MCRetreatment management strategies when first-line tuberculosis therapy fails . Int J Tuberc Lung Dis. 2005;9:421-429.
39.
Shin S., Munoz M., Espiritu B., Zeladita J., Sanchez E., Callacna M., et al. Psychosocial Impact of Poverty on Antiretroviral Nonadherence Among HIV-TB Coinfected Patients in Lima, Peru. J Int Assoc Physicians AIDS Care (Chic Ill). 2008 ;7:74-81.
